Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of generic, branded, and specialty medicines, with a particular focus on sterile injectable products. Founded in 1978 in Amman, Jordan, and headquartered in London, it supplies hospitals and pharmacies across the United States, the Middle East and North Africa, and Europe. The company is listed on the London Stock Exchange.

Hikma operates through three main segments—Injectables, Generics, and Branded—supported by in-house formulation development, aseptic manufacturing, and quality and regulatory capabilities. Its portfolio spans sterile injectables and finished oral and inhalation dosage forms used in critical care and other therapeutic settings. The company maintains a global network of R&D and manufacturing sites to supply essential medicines and help address healthcare system needs, including mitigating drug shortages.